选择性激光小梁成形术治疗青光眼的研究进展  

Researching progress in selective laser trabeculoplasty for glaucoma

作　　者：汤伟(综述)[1] 武志峰(审校)[1] 

机构地区：[1]南京医科大学附属无锡市第二人民医院眼科,无锡214002

出　　处：《中华实验眼科杂志》2014年第2期178-181,共4页Chinese Journal Of Experimental Ophthalmology

摘　　要：青光眼是世界第二位不可逆的致盲性眼病，一旦确诊，需要长期治疗。激光治疗已经成为青光眼治疗的3个主要手段之一，其中选择性激光小梁成形术（SLT）可选择性地作用于色素性小梁组织，使靶组织收缩，房水外流通畅，从而降低青光眼患者的眼压，但其具体作用机制复杂，目前尚不完全明确。由于其对小梁网组织破坏程度轻微，术后反应较轻，且对邻近组织无损伤，因此是一种安全且可重复治疗的手段，并且不会影响青光眼的下一步治疗。就SLT的原理及SLT临床应用的背景、临床疗效、治疗的安全性等进行综述。Glaucoma is the second leading cause of irreversible blindness worldwide. The treatment of glaucomatous eyes is a long-term procedure. Laser treatment is becoming one of the three major methods to lower intraocnlar pressure （IOP） of glaucomatous patients. Selective laser trabeculoplasty （SLT） mainly targets to the pigment cells on the trabecular meshwork and makes it easier for fluid to flow out of the front part of the eye, decreasing pressure in the eye. But, the actual mechanism of this surgery is below understood now. Compared with other laser therapy, SLT uses a lower-level laser to open the drainage angle of the eye, and therefore cause rare or slight complication, so it is thought to be a repeatable therapy to the patients who needs further treatment. The principle,clinical application,efficacy,safety and study progress about SLT for glaucomatous eyes are reviewed.

关 键 词：激光疗法 方法 青光眼 开角型 闭角型 手术 眼压 小梁切除术 小梁成形术 选择性激光小梁成形术 氩激光小梁成形术 色素细胞 

分 类 号：R775.2[医药卫生—眼科]